Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 73.95
-2.45 (-3.21%)
Sep 10, 2026, 11:44 AM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 22.51 billion as of September 9, 2026. Its market cap has decreased by -2.68% in one year.
Market Cap
22.51B
Enterprise Value
19.59B
Revenue
963.56M
Ranking
n/a
PE Ratio
24.39
Stock Price
73.95
ChartMarket Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has increased from 18.43B to 22.51B, an increase of 22.14%. That is a compound annual growth rate of 3.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 22.51B | 42.94% |
| Dec 31, 2025 | 15.75B | 84.90% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
| Jul 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3SBio | 40.95B |
| Shanghai Henlius Biotech | 35.82B |
| Shanghai Junshi Biosciences | 34.17B |
| InnoCare Pharma | 30.62B |
| InSilico Medicine Cayman TopCo | 29.28B |
| Zai Lab | 23.09B |
| Metis TechBio | 20.78B |
| Duality Biotherapeutics | 16.88B |